ONCO

Onconetix Inc

ONCO.US onconetix.com + Research + Basket
CIK 0001782107
Employees 2
Phone 513 620 4101
Fiscal year end December
IPO Feb 18, 2022
Address 201 East Fifth Street, Cincinnati, OH, United States, 45202
0.62
+0.15 (+31.14%)
USD · NASDAQ
52-week range
0.35
200.00
Trading at 0% of the 52-week range
Market Cap
3.57M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
3.55
Div. Yield
N/A
% Institutions
4.92%
% Insiders
0.112%

1 Year

-99.7%

3 Year

-100.0%

10 Year

-100.0%
Description

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

Actions

Add an action for ONCO.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Ms. Karina M. Fedasz Interim Chief Financial Officer 1973
Mr. David Allan White C.A., C.P.A., ICD.D Chief Executive Officer 1953
Mr. Andrew D. Skibo Ph.D. Global Head of Biologics Operations NA
Mr. Theodore Scott Yoho Head of Business Development NA
Dr. Ali I. Fattom Ph.D. Head of Science & Discovery NA
Dr. Jay Newmark M.B.A., M.D. Chief Medical Officer NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 21, 2026 Financial Lp Hrt N/A Sale 49.71K $0.69 $34.30K SEC
Apr 20, 2026 Financial Lp Hrt N/A Sale 94.46K $0.75 $70.85K SEC
Apr 17, 2026 Financial Lp Hrt N/A Purchase 34.64K $0.73 $25.28K SEC
Apr 16, 2026 Financial Lp Hrt N/A Sale 53.87K $0.73 $39.32K SEC
Apr 15, 2026 Financial Lp Hrt N/A Purchase 92.55K $0.76 $70.34K SEC
Apr 14, 2026 Financial Lp Hrt N/A Purchase 74.35K $0.77 $57.25K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
HRT FINANCIAL LLC 51.40K Jun 30, 2026 0.98% $0.00 0.00%
XTX Topco Ltd 13.55K Jun 30, 2026 0.26% $0.00 0.00%
SBI Securities Co Ltd 252.00 Jun 30, 2026 0.00% $0.00 2,000.00%
Tower Research Capital LLC 145.00 Jun 30, 2026 0.00% $0.00 0.00%
Hollencrest Securities, LLC 100.00 Jun 30, 2026 0.00% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 21.00 Jun 30, 2026 0.00% $0.00 0.00%
DRW Securities, LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Danske Bank A/S. 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Geode Capital Management, LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Citigroup Inc 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Bank of America Corp 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
UBS Group AG 0.00 Jun 30, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 22.64K 0.52% ▲ 219.76% Aug 31, 2026

Financial Highlights

▼
Market Cap: $3.57M
EBITDA: $-7.67M
P/E Ratio: $0.00
Book Value: $3.55
Earnings/Share: $310.39
Profit Margin: 0.00%
Operating Margin: -13,112.09%
ROA (TTM): -27.03%
ROE (TTM): -105.23%
Revenue (TTM): $645.82K
Revenue/Share (TTM): $1.09
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -83.90%

Valuation Metrics

Enterprise Value: $-2.96M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 5.89M
Shares Float: 3.95M
% Insiders: 0.112%
% Institutions: 4.92%
Short % Float: 7.44%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$815.37K
Cost of Goods Sold
adjust
$-182.46K
Gross Profit
subtotal
$632.91K
SG&A
adjust
$-7.04M
R&D
adjust
$-66.13K
Operating Income
subtotal
$-6.34M
Other / Non-Operating Items
adjust
$-7.69M
Net Income
subtotal
$-14.03M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ONCO.US!